Back
 AID  Vol.10 No.3 , December 2020
Practical Guideline for Screening the Patients with SARS-CoV-2 Infection and Persian Gulf Criteria for Diagnosis of COVID-19
Abstract: The new Coronavirus disease or COVID-19 is a contagious viral/immune-logical systemic disorder with predominantly respiratory features caused by human infection with SARS-CoV-2, which is rapidly spreading from person-to-person all around the world as a pandemic. The new outbreak of COVID-19 first appeared in Wuhan, China in December 2019. This virus is transmitted from human to human in various ways including air, aerosol, touching, and fecal-oral ways. The SARS-CoV-2 survives for several days in the environment. The SARS-CoV-2 virus multiplies within the cells of mouth-throat or nose-throat, and despite the production of antibodies by the human immune system, if the virus continues to multiply and progress, it will enter the bloodstream and reach its target organ, the lungs. It takes an incubation period of one to fourteen days for the initial symptoms/signs of disease to appear as fever, dry cough, and fatigue. Finally, shortness of breath due to pneumonia/pneumonitis with or without Acute Respiratory Distress Syndrome (ARDS) causes the patient to be hospitalized and transferred to ICU. Older people with underlying disorders account for the majority of deaths from COVID-19, while children under the age of 15 - 20 are the main carriers of the SARS-CoV-2. About 40% of patients with COVID-19 are asymptomatic and, 40% mild, 15%; severe, and 5% are critical COVID-19. COVID-19 Molecular Diagnostic Tests and COVID-19 Antibody Tests are two types of diagnostic kit tests for identification of the SARS-CoV-2 and the High Resolution Computerised Tomography (HRCT) scanning of lungs is the best imaging method for detecting pneumonia/pneumonitis and assessing its severity. This paper is intended to present a health system called COVID-19 Referral System for screening and developing very sensitive diagnostic criteria as Persian Gulf Criteria for diagnosis of COVID-19. By using these two methods and performing the SARS-CoV-2 kit tests more and more widely, and performing accurate isolation of patients and virus carriers and complete quarantine of red zones, it is possible to successfully control the SARS-CoV-2 epidemics.
Cite this paper: Salehi-Abari, I. , Khazaeli, S. , Salehi-Abari, F. and Salehi-Abari, A. (2020) Practical Guideline for Screening the Patients with SARS-CoV-2 Infection and Persian Gulf Criteria for Diagnosis of COVID-19. Advances in Infectious Diseases, 10, 67-93. doi: 10.4236/aid.2020.103008.
References

[1]   Kavanagh, K. (2020) CDC’s Changing Guidance Underscores How COVID-19 Keeps Winning. Journal of the US CDC.

[2]   (2020) SARS-CoV-2 Transmission. Worldometer. Coronavirus.

[3]   Lauer, S.A., et al. (2020) The Incubation Period of Coronavirus Disease 2019 (COVID-19) from Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine.
https://doi.org/10.7326/M20-0504

[4]   McDarison, K. (2020) Reports on Surfaces and COVID-19. New England Journal of Medicine.

[5]   Mehta, P., et al. (2020) COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. The Lancet, 395, 1033-1034.
https://doi.org/10.1016/S0140-6736(20)30628-0

[6]   Jose, I., Junior, M., et al. (2020) The Global Population of SARS-CoV2 Is Composed of Six Major Subtypes.
https://doi.org/10.1101/2020.04.14.040782

[7]   Xu, Z., et al. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet, Respiratory Medicine, 8, 420-422.
https://doi.org/10.1016/S2213-2600(20)30076-X

[8]   Gattinoni, L., et al. (2020) COVID-19 Pneumonia: ARDS or Not? Critical Care, 24, Article No. 154.
https://doi.org/10.1186/s13054-020-02880-z

[9]   Sala, S., Peretto, G., et al. (2020) Acute Myocarditis Presenting as a Reverse Tako-Tsubo Syndrome in a Patient with SARS-CoV-2 Respiratory Infection. European Heart Journal, 41, 1861-1862.

[10]   Hua, A., O’Gallagher, K., et al. (2020) Life-Threatening Cardiac Tamponade Complicating Myo-Pericarditis in COVID-19. European Heart Journal, 41, 2130.

[11]   Mubarak, M., et al. (2020) COVID-19 Nephropathy. Journal of Nephropathology, 9, e21.
https://doi.org/10.34172/jnp.2020.21

[12]   Valizadeh, R. and Baradaran, A. (2020) Coronavirus-Nephropathy; Renal Involvement in COVID-19. Journal of renal Injury Prevention, 9, e18.
https://doi.org/10.34172/jrip.2020.18

[13]   Yeo, C., et al. (2020) Enteric Involvement of Coronavirus: Is Fecal-Oral Transmission of SARS-CoV-2 Possible? The Lancet Gastroenterology & Hepatology, 5, 335-337.
https://doi.org/10.1016/S2468-1253(20)30048-0

[14]   Zhang, C., et al. (2020) Liver Injury in COVID-19. The Lancet Gastroenterology & Hepatology, 5, 428-430.
https://doi.org/10.1016/S2468-1253(20)30057-1

[15]   Baig, A.M. (2020) Neurological Manifestations in COVID-19 Caused by SARS-CoV-2.
https://doi.org/10.1111/cns.13372

[16]   Coronavirus: Information & Resources, National Jewish Health Coronavirus: Information & Resources. COVID-19 (Coronavirus) Antibody & Molecular Diagnostic Testing Available.

[17]   Vlahovic, T. (2020) COVID-19 Skin Manifestations and the Foot: Podiatry Today.

[18]   Luchen, et al. (2020) Ocular Manifestations of a Hospitalized Patient with Confirmed COVID-19. British Journal of Ophthalmology.
https://doi.org/10.1136/bjophthalmol-2020-316304

[19]   So, W. (2020) Age Distribution of Coronavirus (COVID-19) Cases in South Korea as of May 8, 2020. Statista; Health & Pharmaceuticals, State of Health.

[20]   Elflein, J. (2020) Age Distribution of Canadian COVID-19 Cases as of May 13, 2020. Statista; Health & Pharmaceuticals, State of Health.

[21]   CDC: Centers for Disease Control and Prevention CDC 24/7: Saving Lives, Protecting People; Coronavirus COVID-19.

[22]   WHO (2020) News and Events Regarding COVID-19 and SARS CoV-2.

[23]   (2020) COVID-19 Sex Disaggregated Data Tracker. Sex, Gender and COVID-19. Global Health 5050.

[24]   (2020) News regarding COVID-19: American Academy of Otolaryngology—Head and Neck Surgery.

[25]   Green, K., et al. (2020) What Tests Could Potentially Be Used for the Screening, Diagnosis and Monitoring of COVID-19 and What Are Their Advantages and Disadvantages. CEBM; The Centre for Evidence-Based Medicine Develops, Promotes and Disseminates Better Evidence for Healthcare.
https://doi.org/10.1016/j.ejrad.2020.109009

[26]   Li, R., Pei, S., Chen, B., et al. (2020) Substantial Undocumented Infection Facilitates the Rapid Dissemination of Novel Coronavirus (SARS-CoV-2). Science, 368, 489-493.
https://doi.org/10.1126/science

[27]   Ding, X., et al. (2020) Chest CT Findings of COVID-19 Pneumonia by Duration of Symptoms. European Journal of Radiology, 127, Article ID: 109009.

[28]   (2020) Age, Sex, Existing Conditions of COVID-19 Cases and Deaths. Worldometer.

[29]   Giacomelli, A., et al. (2020) Self-Reported Olfactory and Taste Disorders in SARS-CoV2 Patients. Clinical Infectious Disorder.
https://doi.org/10.1093/cid/ciaa330

 
 
Top